Cystic fibrosis carrier screening by DNA analysis: a pilot study of attitudes among participants.

Por Kaplan, F, Clow, C, Scriver, C R
Publicado em 1991

Phenylketonuria and diet.

Por Scriver, C. R., Katz, L., Clow, C.
Publicado em 1968

Hereditary tyrosinemia and tyrosyluria: clinical report of four patients.

Por Scriver, C. R., Silverberg, M., Clow, C. L.
Publicado em 1967

Neonatal hypertyrosinemia and evidence for deficiency of ascorbic acid in Arctic and subarctic peoples.

Por Clow, C. L., Laberge, C., Scriver, C. R.
Publicado em 1975

What young people think and do when the option for cystic fibrosis carrier testing is available.

Por Mitchell, J, Scriver, C R, Clow, C L, Kaplan, F
Publicado em 1993

Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools.

Por Mitchell, J. J., Capua, A., Clow, C., Scriver, C. R.
Publicado em 1996

Prevention of mental retardation in offspring of hyperphenylalaninemic mothers.

Por Cartier, L, Clow, C L, Lippman-Hand, A, Morissette, J, Scriver, C R
Publicado em 1982

Beta-thalassemia disease prevention: genetic medicine applied.

Por Scriver, C R, Bardanis, M, Cartier, L, Clow, C L, Lancaster, G A, Ostrowsky, J T
Publicado em 1984

The Hartnup phenotype: Mendelian transport disorder, multifactorial disease.

Por Scriver, C R, Mahon, B, Levy, H L, Clow, C L, Reade, T M, Kronick, J, Lemieux, B, Laberge, C
Publicado em 1987

Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec.

Por Scriver, C R, Gregory, D, Bernstein, M, Clow, C L, Weisdorf, T, Dougherty, G E, Auray-Blais, C, Giguère, R, Lemieux, B, Laberge, C
Publicado em 1987